Bank of America and Mizuho issued rating changes and price targets for Haemonetics on August 1, 2026.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America and Mizuho issued rating changes and price targets for Haemonetics on August 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Haemonetics
company based in Braintree, Massachusetts, USA
-
Bank of America
American multinational banking and financial services corporation
-
Mizuho
city in Gifu prefecture, Japan
Nothing else this week.
Related events
- Bank of America influenced stock rating and target price for Commercial Metals Company, with MarketBeat aggregating the data.
- Bank of America and Citigroup issued buy ratings and raised price targets on July 18, 2026.
- Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
- Multiple financial institutions issued rating changes and price targets across various sectors, including tech, industrial, and hospitality.
- Bank of America set a buy rating and price target for Penguin Solutions on October 23, 2026.